Beijing, China · Founded 2018 · In IPO Registration
Developer of innovative drugs for tumor treatment. Avistone Pharmaceuticals Biotechnology is based in Beijing, China and was founded in 2018. Its last reported valuation was $628 million in Mar 2025. It has raised $372 million.
Last reported valuation
$628.3M
Oct 2026
Priced at
—
Total raised
$372.0M
Last round
—
Team — not yet on record
No current team members for Avistone Pharmaceuticals Biotechnology are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Avistone Pharmaceuticals Biotechnology with a free account
·The complete investor list: 11 names
·Watch Avistone Pharmaceuticals Biotechnology: the Monday email on marks, rounds and moves
